Materials and methods for bleaching melanin-pigmented tissues
US-2024361213-A1 · Oct 31, 2024 · US
US10345202B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10345202-B2 |
| Application number | US-201414532252-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 4, 2014 |
| Priority date | Nov 15, 2013 |
| Publication date | Jul 9, 2019 |
| Grant date | Jul 9, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method ( 100 ) for fixing at least one tissue sample ( 1 ) is carried out using a tissue processor ( 10 ). The tissue sample ( 1 ) is introduced at a first temperature level and a first pressure level into a fixing reagent ( 2 ) containing at least one nitrogen-containing compound capable of pressure- and/or temperature-dependent release of at least one aldehyde. The tissue sample ( 1 ) is left in the fixing reagent ( 2 ) for a fixing time period during which the fixing reagent ( 2 ) is brought to a second temperature level above the first temperature level and/or to a second pressure level above the first pressure level. A concentration in the fixing reagent ( 2 ) of the nitrogen-containing compound is ascertained using at least one concentration measuring device ( 14 ) of the tissue processor ( 10 ), and a signal is outputted on the basis of a measured value of the at least one concentration measuring device ( 14 ).
Opening claim text (preview).
What is claimed is: 1. A tissue processor ( 10 ) comprising: at least one process chamber ( 12 ) configured to receive a sample container ( 11 ) having at least one tissue sample ( 1 ) introduced into a fixing reagent ( 2 ), the fixing reagent ( 2 ) containing at least one nitrogen-containing compound capable of pressure- and/or temperature-dependent release of at least one aldehyde, wherein the at least one nitrogen-containing compound capable of pressure-and/or temperature-dependent release of at least one aldehyde includes urotropin, at least one triazine, dimethyloldihydroxyethylene urea, mono-, di, tri-, tetra-, penta-, and hexamethylolmelamine, tetramethylolacetylene diurea, dimethylolpropylene urea, acetoguanamine, and/or 5,5-dimethylhydantoin; a reservoir container ( 13 ) in fluid communication with the sample container ( 11 ), the reservoir container storing fixing reagent ( 2 ); a concentration measuring device ( 14 ) associated with the reservoir container ( 13 ), wherein the concentration measuring device ( 14 ) is configured to ascertain a concentration in fixing reagent ( 2 ) of the at least one nitrogen-containing compound capable of pressure- and/or temperature-dependent release of the at least one aldehyde; and a control system operatively connected to the concentration measuring device, wherein the control system is programmed to operate the tissue processor ( 10 ), and wherein the tissue processor modifies at least one of a fixing time, a pressure, and a temperature of a fixing operation based on the concentration ascertained by the concentration measuring device; wherein the tissue processor ( 10 ) further comprises at least one of: a pressure pump in fluid communication with the at least one process chamber ( 12 ) for increasing pressure within the at least one process chamber ( 12 ), wherein the pressure pump is operatively connected to the control system; and a heating coil within the at least one process chamber ( 12 ), wherein the heating coil is operatively connected to the control system. 2. The tissue processor ( 10 ) according to claim 1 , wherein the concentration measuring device ( 14 ) includes a spectrophotometric concentration measuring device. 3. The tissue processor ( 10 ) according to claim 1 , wherein the control system further comprises a keypad and screen, and wherein the concentration measuring device ( 14 ) outputs a measured value signal to the screen.
Related publications grouped by family.
Answers are generated from the same data shown on this page.